# Maintenance of an Antiaggregation by Acetylsalicylic Acid, While a Extracorporeal Lithotripsy Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study

> **NCT03437057** · NA · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 300 (estimated)

## Conditions studied

- Renal Lithiasis
- Antiplatelet
- Hematoma

## Interventions

- **OTHER:** acetylsalicylic acid (below or equal to) 250 mg

## Key facts

- **NCT ID:** NCT03437057
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-08
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03437057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03437057, "Maintenance of an Antiaggregation by Acetylsalicylic Acid, While a Extracorporeal Lithotripsy Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03437057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
